Andrew Stamford;William J. Greenlee;Jack D. Scott;Chander Shekher Celly;Eric J. Gilbert;Michael W. Miller;Duane Eugene DeMong
发明人:
Eric J. Gilbert,Michael W. Miller,Jack D. Scott,Duane Eugene DeMong,Andrew Stamford,William J. Greenlee,Chander Shekher Celly
申请号：
US12146039
公开号：
US08623873B2
申请日:
2008.06.25
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Compounds of Formula (I):or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
